viernes, 27 de septiembre de 2024
Emergency Use Authorizations for Drugs and Non-Vaccine Biological Products - FDA updates Pemgarda’s SARS-CoV-2 variant susceptibility data
https://www.fda.gov/drugs/emergency-preparedness-drugs/emergency-use-authorizations-drugs-and-non-vaccine-biological-products?utm_medium=email&utm_source=govdelivery
FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION OF PEMGARDA
(PEMIVIBART)
https://www.fda.gov/media/177067/download?attachment=&utm_medium=email&utm_source=govdelivery
https://www.fda.gov/media/182220/download?utm_medium=email&utm_source=govdelivery
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario